Cost Utility of Intermittent Inhaled Corticosteroids in Preschoolers with Viral-Triggered Wheeze

Background: Evidence has demonstrated that adding intermittent inhaled corticosteroids (ICS) to treatment with short-acting b2-agonists (SABAs) in children 5 years of age and younger who experience intermittent viral-induced wheezing (VIW) reduces the risk of severe exacerbations. However, there is...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Pediatric allergy, immunology, and pulmonology immunology, and pulmonology, 2022-03, Vol.35 (1), p.36-42
Hauptverfasser:	Buendía, Jefferson Antonio, Guerrero Patiño, Diana, Giraldo Ramírez, Juan Esteban
Format:	Artikel
Sprache:	eng
Schlagworte:	Adrenal Cortex Hormones - therapeutic use Age Anti-Asthmatic Agents Asthma Asthma - drug therapy Child Children Corticoids Corticosteroids Cost analysis Health care Humans Markov chains Original Research Patients Quality-Adjusted Life Years Respiratory Sounds Sensitivity analysis Steroids Wheezing
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!